Table 1 Demographic and laboratory data of the cholestatic patients
From: Zinc status in infants and children with cholestatic liver diseases and its effect on growth
Variables | |
|---|---|
Sex (male/female) | 32/23 |
Age (years) (median (IQR), [range]) | 2.2 (2.7), [0.5:10] |
Diagnosis | |
Post-Kasai | 27 (49%) |
Other cholestatic diseases | 28 (51%) |
Total serum bilirubin (mg/dl) (median (IQR), [range]) | 1.8 (11), [0.2:31] |
Direct serum bilirubin (mg/dl) (median (IQR), [range]) | 1.4 (8.4), [0.00:21] |
ALT (u/l) (median (IQR), [range]) | 69 (77), [13:502] |
AST (u/l) (median (IQR), [range]) | 100 (174), [37:493] |
ALK (u/l) (median (IQR), [range]) | 487 (446), [104:1718] |
GGT (u/l) (median (IQR), [range]) | 112 (321), [5:775] |
Serum albumin (g/dl) (mean ± SD) | 3.4 ± 0.9 |
INR (mean ± SD) | 1.3 ± 0.7 |
Hb (g/dl) (mean ± SD) | 10.8 ± 1.6 |
TLC (median (IQR), [range]) | 7.4 (4.1), [1.9:70] |
Platelet median (IQR), [range]) | 199 (212), [42:577] |